skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Index

Results 1 - 50 of 400  for Everything (Includes Articles)

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to e-Shelf

Systematic approach for trace level quantification of 2-n-butyl-4-spirocyclopentane-2-imidazole-5-one genotoxic impurity in irbesartan using lc-ms/ms

Reddy, A ; Venugopal, N ; Madhavi, G ; Madhavi, V ; Reddy, K

Indian Journal of Pharmaceutical Sciences, 2013, Vol.75(5), p.501-506 [Peer Reviewed Journal]

Full text available

View all versions
2
Material Type:
Article
Add to e-Shelf

Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: Influence of pH and excipients

Muankaew, Chutimon ; Jansook, Phatsawee ; Stefánsson, Einar ; Loftsson, Thorsteinn

International Journal of Pharmaceutics, 20 October 2014, Vol.474(1-2), pp.80-90 [Peer Reviewed Journal]

Full text available

View all versions
3
Material Type:
Article
Add to e-Shelf

Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines

Georgescu, Adriana ; Alexandru, Nicoleta ; Nemecz, Miruna ; Titorencu, Irina ; Popov, Doina

European Journal of Pharmacology, 05 July 2013, Vol.711(1-3), pp.27-35 [Peer Reviewed Journal]

Full text available

View all versions
4
Material Type:
Article
Add to e-Shelf

Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats

Ibrahim, Mohamed A ; Amin, Entesar F ; Ibrahim, Salwa A ; Abdelzaher, Walaa Y ; Abdelrahman, Aly M

European Journal of Pharmacology, 05 February 2014, Vol.724, pp.204-210 [Peer Reviewed Journal]

Full text available

View all versions
5
Material Type:
Article
Add to e-Shelf

Irbesartan inhibits advanced glycation end product-induced increase in asymmetric dimethylarginine level in mesangial cells through its anti-oxidative properties

Ishibashi, Yuji ; Matsui, Takanori ; Ueda, Seiji ; Fukami, Kei ; Okuda, Seiya ; Yamagishi, Sho-Ichi

International Journal of Cardiology, 20 October 2014, Vol.176(3), pp.1120-1122 [Peer Reviewed Journal]

Full text available

View all versions
6
Material Type:
Article
Add to e-Shelf

Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study

Kim, Sang-Hyun ; Jo, Sang-Ho ; Lee, Sang-Cheol ; Lee, Sung-Yoon ; Yoon, Myung-Ho ; Lee, Hyang-Lim ; Lee, Nae-Hee ; Ha, Jong-Won ; Lee, Nam-Ho ; Kim, Dong-Woon ; Han, Gyu-Rok ; Hyon, Min-Su ; Cho, Deok-Gyu ; Park, Chang-Gyu ; Kim, Young-Dae ; Ryu, Gyu-Hyung ; Kim, Cheol-Ho ; Kim, Kee-Sik ; Chung, Myung-Ho ; Chae, Sung-Chul ; Seung, Ki-Bae ; Oh, Byung-Hee

Clinical Therapeutics, October 2016, Vol.38(10), pp.2171-2184 [Peer Reviewed Journal]

Full text available

View all versions
7
Material Type:
Article
Add to e-Shelf

Irbesartan promotes erection recovery after nerve‐sparing radical retropubic prostatectomy: a retrospective long‐term analysis

Segal, Robert L. ; Bivalacqua, Trinity J. ; Burnett, Arthur L.

BJU International, December 2012, Vol.110(11), pp.1782-1786 [Peer Reviewed Journal]

Full text available

View all versions
8
Material Type:
Article
Add to e-Shelf

Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy

Behl, Tapan ; Kotwani, Anita

Life Sciences, 01 May 2017, Vol.176, pp.1-9 [Peer Reviewed Journal]

Full text available

View all versions
9
Material Type:
Article
Add to e-Shelf

Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway

Cheng, Yan-Zhen ; Yang, Shuang-Li ; Wang, Ji-Yu ; Ye, Meng ; Zhuo, Xiao-Yun ; Wang, Li-Tao ; Chen, Hong ; Zhang, Hua ; Yang, Li

Life Sciences, 15 July 2018, Vol.205, pp.184-192 [Peer Reviewed Journal]

Full text available

View all versions
10
Material Type:
Article
Add to e-Shelf

Electrochemical determination of antihypertensive drug irbesartan in pharmaceuticals

Gupta, Vinod K ; Jain, Rajeev ; Agarwal, Shilpi ; Mishra, Ritesh ; Dwivedi, Ashish

Analytical Biochemistry, 15 March 2011, Vol.410(2), pp.266-271 [Peer Reviewed Journal]

Full text available

View all versions
11
Material Type:
Article
Add to e-Shelf

Retrospective Analysis of Real-World Efficacy of Angiotensin Receptor Blockers Versus Other Classes of Antihypertensive Agents in Blood Pressure Management

Petrella, Robert ; Michailidis, Paul

Clinical Therapeutics, 2011, Vol.33(9), pp.1190-1203 [Peer Reviewed Journal]

Full text available

View all versions
12
Material Type:
Article
Add to e-Shelf

A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide

Dong, Zhongqi ; Ekins, Sean ; Polli, James E

International Journal of Pharmaceutics, 15 January 2015, Vol.478(1), pp.88-95 [Peer Reviewed Journal]

Full text available

View all versions
13
Material Type:
Article
Add to e-Shelf

Inulin and poly(acrylic acid) grafted inulin for dissolution enhancement and preliminary controlled release of poorly water-soluble Irbesartan drug

Fares, Mohammad M ; Salem, Mu’taz Sheikh ; Khanfar, Mai

International Journal of Pharmaceutics, 2011, Vol.410(1), pp.206-211 [Peer Reviewed Journal]

Full text available

View all versions
14
Material Type:
Article
Add to e-Shelf

AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress

Boccellino, Mariarosaria ; Di Domenico, Marina ; Donniacuo, Maria ; Bitti, Giuseppe ; Gritti, Giulia ; Ambrosio, Pasqualina ; Quagliuolo, Lucio ; Rinaldi, Barbara

PloS one, 2018, Vol.13(10), pp.e0202297 [Peer Reviewed Journal]

Full text available

View all versions
15
Material Type:
Article
Add to e-Shelf

Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats

Tang, Ri-Ning ; Lv, Lin-Li ; Zhang, Jian-Dong ; Dai, Hou-Yong ; Li, Qing ; Zheng, Min ; Ni, Jie ; Ma, Kun-Ling ; Liu, Bi-Cheng

International Journal of Cardiology, 10 January 2013, Vol.162(2), pp.92-99 [Peer Reviewed Journal]

Full text available

View all versions
16
Material Type:
Article
Add to e-Shelf

Does improved insulin sensitivity by irbesartan at the highest tolerated dose provide a benefit in non-diabetic patients with systolic heart failure already receiving standardized treatment?

Yang, Dan ; Liu, Zhihong

International Journal of Cardiology, 30 September 2013, Vol.168(2), pp.1572-1573 [Peer Reviewed Journal]

Full text available

View all versions
17
Material Type:
Article
Add to e-Shelf

Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells

Kobayashi, Tatsuo ; Akiyama, Yuko ; Akiyama, Nobuteru ; Katoh, Hideaki ; Yamamoto, Sachiko ; Funatsuki, Kenzo ; Yanagimoto, Toru ; Notoya, Mitsuru ; Asakura, Kenji ; Shinosaki, Toshihiro ; Hanasaki, Kohji

European Journal of Pharmacology, 2010, Vol.649(1), pp.23-28 [Peer Reviewed Journal]

Full text available

View all versions
18
Material Type:
Article
Add to e-Shelf

Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan

Patel, Jaydeep ; Patel, Anjali ; Raval, Mihir ; Sheth, Navin

Journal of Advanced Pharmaceutical Technology & Research, 2011, Vol.2(1), p.9-16 [Peer Reviewed Journal]

Full text available

View all versions
19
Material Type:
Article
Add to e-Shelf

Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies

Soma, Deepthi ; Attari, Zenab ; Reddy, Meka Sreenivasa ; Damodaram, Atmakuri ; Koteshwara, Kunnatur Balasundara Gupta

Brazilian Journal of Pharmaceutical Sciences, 01 April 2017, Vol.53(1) [Peer Reviewed Journal]

Full text available

View all versions
20
Material Type:
Article
Add to e-Shelf

Effects of low-dose spironolactone combined with irbesartan on cardiac hypertrophy induced by pressure overload in rats

Ma, Jingtao ; Zhang, Hongxue ; Guo, Huicai ; Xu, Yanfang

American journal of translational research, 2014, Vol.6(6), pp.809-19 [Peer Reviewed Journal]

Full text available

21
Material Type:
Article
Add to e-Shelf
22
Material Type:
Article
Add to e-Shelf
23
Material Type:
Article
Add to e-Shelf

Simultaneous Analysis of Irbesartan and Hydrochlorothiazide: An Improved HPLC Method with the Aid of a Chemometric Protocol

Predrag Stankovic ; Jasmina Brborić ; Zorica Vujić ; Miralem Smajić ; Nedžad Mulavdić

Molecules, 01 March 2012, Vol.17(3), pp.3461-3474 [Peer Reviewed Journal]

Full text available

View all versions
24
Material Type:
Article
Add to e-Shelf

Comparative bioavailability of a newly developed Irbesartan 300 mg containing preparation

Petrov Andrey D ; Gatchev Emil M ; Kalinov Krasimir B ; Filipova Elena P ; Uzunova Katya H ; Vekov Toni Y

Hospital Pharmacology, 01 January 2018, Vol.5(2), pp.638-646

Full text available

25
Material Type:
Article
Add to e-Shelf

EFFECT OF IRBESARTAN ON BIOCHEMICAL PARAMETERS IN OVERWEIGHT HYPERTENSIVE PATIENTS

M. Balachandra Rao Naidu ; Ch. Ratna Kumar ; Kiranmai

Journal of Evidence Based Medicine and Healthcare, 01 June 2016, Vol.3(52), pp.2668-2670

Full text available

26
Material Type:
Article
Add to e-Shelf

Irbesartan drug formulated as nanocomposite particles for the enhancement of the dissolution rate

Zhang, Zhiliang ; Le, Yuan ; Wang, Jiexin ; Zhao, Hong ; Chen, Jianfeng

Particuology, August 2012, Vol.10(4), pp.462-467

Full text available

View all versions
27
Material Type:
Article
Add to e-Shelf

A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide

Khodke, Amol ; Potale, Laxman ; Damle, Mrinalini ; Bothara, Kailash

Pharmaceutical Methods, 2010, Vol.1(1), p.39-43 [Peer Reviewed Journal]

Full text available

View all versions
28
Material Type:
Article
Add to e-Shelf

Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats

Chen, Gin - Fu ; Wagner, Laszlo ; Sasser, Jennifer M ; Zharikov, Sergey ; Moningka, Natasha C ; Baylis, Chris

Nephrology Dialysis Transplantation, 2010, Vol. 25(11), pp.3518-3525 [Peer Reviewed Journal]

Full text available

View all versions
29
Material Type:
Article
Add to e-Shelf

Antihypertensive treatment in patients with class 3 obesity

Jordan, Jens ; Boye, Sam W ; Breton, Stephanie Le ; Keefe, Deborah L ; Engeli, Stefan ; Prescott, Margaret Forney

Therapeutic Advances in Endocrinology and Metabolism, June 2012, Vol.3(3), pp.93-98 [Peer Reviewed Journal]

Full text available

View all versions
30
Material Type:
Article
Add to e-Shelf

Efficiency assessment for antihypertensive, hemodynamic, renal effects of adenosine-converting enzyme (ACE) inhibitors and irbesartan and impact on endothelial disfunction in patients with stage II hypertension

M. V. Pereviazkina

Zaporožskij Medicinskij Žurnal, 01 August 2014, Issue 4, pp.12-15 [Peer Reviewed Journal]

Full text available

31
Material Type:
Article
Add to e-Shelf

Influence of irbesartan combined with low dose urokinase on treatment effect and serologic indexes in elderlyisolated systolic hypertension patients

Gui-Peng Wang ; Xiao-Mei Luo

Journal of Hainan Medical University, 01 January 2017, Vol.23(1), pp.33-36 [Peer Reviewed Journal]

Full text available

32
Material Type:
Article
Add to e-Shelf

Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I‐PRESERVE) trial

Cannon, Jane A. ; Shen, Li ; Jhund, Pardeep S. ; Anand, Inder S. ; Komajda, Michel ; Mckelvie, Robert S. ; Zile, Michael R. ; Carson, Peter E. ; Mcmurray, John J. V.

European Journal of Heart Failure, August 2016, Vol.18(8), pp.1021-1031 [Peer Reviewed Journal]

Full text available

View all versions
33
Material Type:
Article
Add to e-Shelf

A gender-specific association of the polymorphism Ile197Met in the kininogen 1 gene with plasma irbesartan concentrations in Chinese patients with essential hypertension

Hu, Shengnan ; Cheng, Jun ; Weinstock, Justin ; Fan, Xiu ; Venners, Scott A ; Hsu, Yi-Hsiang ; Suwen Wu, Faming ; Pan, Xiangdong ; Zha, Jinlu ; Sun, Shanqun ; Jiang, Xiping ; Xu, Xiping

Journal of human hypertension, November 2018, Vol.32(11), pp.781-788 [Peer Reviewed Journal]

Full text available

View all versions
34
Material Type:
Article
Add to e-Shelf

IRBESARTAN IN THE CLINICAL PRACTICE

V. I. Podzolkov ; A. I. Tarzimanova

Racionalʹnaâ Farmakoterapiâ v Kardiologii, 01 September 2015, Vol.10(6), pp.659-664 [Peer Reviewed Journal]

Full text available

View all versions
35
Material Type:
Article
Add to e-Shelf

Efectos renoprotectores a largo plazo de dosis altas de irbesartán en la nefropatía diabética establecida

Ros Ruiz, Silvia ; Aranda Lara, Pedro ; Frenández, Juan C. ; Martínez Esteban, M. D. ; Jironda Gallegos, Cristina ; Hidalgo, P. ; Hernández Marrero, Domingo

Nefrología: publicación oficial de la Sociedad Española de Nefrología, 2012, Vol.32(2), pp.187-196 [Peer Reviewed Journal]

Full text available

View all versions
36
Material Type:
Article
Add to e-Shelf

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman

Al Balushi, K.A ; Habib, J.Q ; Al-Zakwani, I

Medical Principles and Practice, March 2013, Vol.22(3), pp.265-269 [Peer Reviewed Journal]

Full text available

37
Material Type:
Article
Add to e-Shelf

The Role of Irbesartan in the Treatment of Patients with Hypertension

Borghi, Claudio ; Cicero, Arrigo

High Blood Pressure & Cardiovascular Prevention, 2012, Vol.19(1), pp.19-31 [Peer Reviewed Journal]

Full text available

View all versions
38